1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Grants & Donations (Rare Diseases) is sponsored by Sarepta Therapeutics. Sarepta Therapeutics provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote the highest standards of care, raise awareness of ongoing research, or focus on other critical community initiatives across the spectrum of neuromuscular and rare diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grants & Giving | Sarepta Corporate Rebuild Serving the rare disease community through corporate giving programs Program & Event Sponsorships Giving: A Core Part of Our Mission Serving the rare disease community goes beyond developing precision genetic medicines. Sarepta is committed to providing support at every stage of a patient’s journey. Our partnerships with patient advocacy groups are fundamental to this work.
We provide grants, donations, medical education support, and sponsorships to advocacy groups, nonprofit organizations, academic institutions, scientific and medical associations, continuing medical education providers, and other organizations across the spectrum of neuromuscular and rare diseases, with priority assigned to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other disease areas of focus for the company.
Sarepta provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote the highest standards of care, raise awareness of ongoing research, or focus on other critical community initiatives.
Requests will be considered across the spectrum of neuromuscular and rare diseases, with priority assigned to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other disease areas of focus for the company. Applications are accepted on a rolling basis and are generally reviewed monthly by the committee. Our team will review your request and contact you within 90 days of your submission.
Requests considered may include those that support: the communities Sarepta serves globally programs and activities that seek to advance medical and disease education, and that address the unmet needs of patients charitable causes and events that are of importance to the communities we serve collaborative learning experiences through engagement with various stakeholders from the Duchenne community programs that target a broad population of patients Requests that typically cannot be supported may include: funds that will benefit an individual or specific subset of the disease community proposals for support of general education or programs if one of Sarepta’s disease areas of focus are not highlighted programs that duplicate efforts that are actively ongoing in the community or that Sarepta has already supported If you have any questions about grants or sponsorships, please contact: grantsandsponsorships@sarepta.
com . Sarepta sponsors programs and events that support, raise awareness, and advance education and scientific knowledge around rare diseases and the experience of patients living with those diseases. Sarepta’s funding priorities include support programs that focus on neuromuscular and rare disorders, with priority on Duchenne muscular dystrophy and limb-girdle muscular dystrophy.
Applications are accepted on a rolling basis throughout the year and are generally reviewed monthly by the committee. Our team will review your request and contact you within 90 days of your submission. Sponsorship applications must include a list of the benefits for each funding level.
If you have any questions about grants or sponsorships, please contact grantsandsponsorships@sarepta. com .
According to the current listing, eligibility includes: Advocacy groups, nonprofit organizations, academic institutions, scientific and medical associations, and continuing medical education providers. Priority is assigned to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other disease areas of focus for the company. Confirm the full requirements in the official notice before applying.
Applications for Grants & Donations (Rare Diseases) are due November 15, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Grants & Donations (Rare Diseases) is funded by Sarepta Therapeutics. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
Grants for Rare Disease Programs is sponsored by Sarepta Therapeutics. Sarepta provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote the highest standards of care, raise awareness of ongoing research, or focus on other critical community initiatives. Requests are considered across the spectrum of neuromuscular and rare diseases, with priority given to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other conditions. [16]
Grants & Donations (Rare Disease Community) is sponsored by Sarepta Therapeutics. Sarepta Therapeutics provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote high standards of care, raise awareness of ongoing research, or focus on other critical community initiatives. Priority is given to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other disease areas of focus for the company, but requests are considered across the spectrum of neuromuscular and rare diseases.